Gilead Sciences (GILD) Revenue
Gilead Sciences Revenue
Gilead Sciences had a revenue of 8.30B in the quarter ending Sep 30, 2026, with 6.37%. This bring the company's revenue in the last twelve months to 30.99B, Increased 1.74%. In the fiscal year ending Dec 31, 2025, Gilead Sciences had annual revenue of 29.44B with 2.39% growth.
- Revenue (ttm)
- 30.99B
- Revenue Growth
- -4.01%
- P/S Ratio
- 135.04
- Revenue/Employee
- MXN 1,731,882
- Employees
- 17,000
- Market Cap
- MXN 3.98T
Revenue Chart
Gilead Sciences Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 29.44B | 688.00M | 2.39% |
| Dec 31, 2024 | 28.75B | 1.64B | 6.04% |
| Dec 31, 2023 | 27.12B | -165.00M | -0.60% |
| Dec 31, 2022 | 27.28B | -24.00M | -0.09% |
| Dec 31, 2021 | 27.30B | 2.62B | 10.60% |
| Dec 31, 2020 | 24.69B | 2.24B | 9.98% |
| Dec 31, 2019 | 22.45B | 322.00M | 1.46% |
| Dec 31, 2018 | 22.13B | -3.98B | -15.24% |
| Dec 31, 2017 | 26.11B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.